20 slides from Mlp Saglik Hizmetleri As Class B's earnings presentation, Mar 9, 2026
Slide 1: MLPCARE FY 2025 Presentation
MLPCARE FY 2025 PRESENTATION M a r c h 9 th, 2 0 2 6
Slide 2: Forward Looking Statements
Forward Looking Statements This presentation may contain certain forward-looking statements concerning MLP Care’s future performance and should be considered as good faith estimates made by the Company. These forward-looking statements reflect management expectations and are based upon currently ava
Slide 3: Muharrem Usta, Chairman & CEO
MUHARREM USTA CHAIRMAN & CEO
Slide 4: 2025 Financials at a Glance
2025 Financials at a Glance • Revenue growth supported by private medical insurance Revenue EBITDA • EBITDA improvement was driven by favourable TL 55,093m TL 15,328 m revenue mix and ongoing efficiency initiatives 6% Growth 15% Growth Q4 2025: Q4 2025: 4% Growth 26% Growth • Net debt to EBITDA rati
Slide 5: Expanding its Network in Türkiye
Expanding its Network in Türkiye Medical Park İstinye University İstinye University Medical Park TEM Hospital Gaziosmanpaşa Hospital İstanbul Onkoloji Hospital Liv Hospital Topkapı Location: Istanbul / Türkiye Location: Istanbul / Türkiye Location: Istanbul / Türkiye Location: Istanbul / Türkiye Ope
Slide 6: Expanding its Network in Türkiye: City Hospital
Expanding its Network in Türkiye 13 City 34 Hospital 6
Slide 7: Slide 7
Slide 8: Revenue Is up by 6%
Revenue Is up by 6% Revenue (TLm) 6.0% 55,093 51,951 4.1% 14,164 13,602 Q4 2024 Q4 2025 2024 2025 Denotes growth of Revenue vs. the same period of the last year 8
Slide 9: Continued Improvement in Average Prices
Continued Improvement in Average Prices Outpatient Revenues (TLm) Inpatient Revenues (TLm) 14.3% 4.9% 11.6% 1.8% 2.7% 3.1% 2.465 737 420 583 24,336 23,771 24,928 21,289 23.771 24.508 2024 Volume & Mix Price 2025 2024 Volume & Mix Price 2025 Average Revenue Per Visit (ARPV) Average Revenue Per Protoc
Slide 10: EBITDA is up by 15%
EBITDA is up by 15% EBITDA (TLm)1 14.8% 15,328 13,355 26.4% 4,418 3,496 Q4 2024 Q4 2025 2024 2025 1 EBITDA and EBITDA margin calculated by deducting general administrative expenses from gross profit and adding depreciation and amortization expenses Denotes growth of EBITDA vs. the same period of the
Slide 11: Prudent Cost Management
Prudent Cost Management Cost of Service and G&A Expenses as a % of Revenues Cost Saving Measures enables us to reach the favourable EBITDA Margin EBITDA Margin 25.7% 31.2% 25.7% 27.8% 10,6% 9,8% Material costs as a % of revenue decreased by 112bps 10,2% in 2025 driven by effective inventory manage
Slide 12: Net Income
Net Income Net Profit (TLm) Equity Holders of the Parent (18.8%) 6.820 5.537 7.3% 1.284 1.198 Q4 2024 Q4 2025 2024 2025 Denotes growth/decrease of Net Profit and Net Profit Allocated to Equity Holders of the Parent vs. the same period of the last year 12
Slide 13: Net Debt Ratio Improves
Net Debt Ratio Improves Leverage Net Debt Net Debt excl. IFRS 16 11,958 4,869 6,887 0.8x 0.5x 0.3x 934 0.1x 2024 2025 2024 2025 *All figures are presented in million Turkish Lira 13 Denotes Net Debt / EBITDA multiples
Slide 14: CapEx Focused on Future Expansion
CapEx Focused Leverage on Future Expansion Ratio Improves CapEx increased by TL 6.6 billion year-on-year in the 2025, mainly driven by expansion investments to secure future growth million TL 2025 2024 Maintenance: Includes floor openings, Total CapEx 11,266 4,639 renovations and medical equipme
Slide 15: Cash Flow
Cash Flow million TL 2025 2024 Change Operating Cash Flow decreased due EBITDA 15,328 13,355 1,973 to increased working capital requirements, cash outflows related to Changes in working capital (616) 828 (1,444) lease liabilities, and higher tax Tax paid (1,371) (1,069) (303) payments Other (3,145
Slide 16: Q&A
Q&A
Slide 17: Closing Remarks
Closing Remarks MUHARREM USTA CHAIRMAN & CEO
Slide 18: Historical Balance Sheet
Historical Balance Sheet Audited Audited TLm December 31, 2025 December 31, 2024 Cash and cash equivalents 8,401 3,570 Trade receivables 9,827 7,967 Inventory 1,110 1,314 Short term other assets 2,450 1,793 Current assets 21,428 14,644 Tangible and intangible fixed assets 32,182 22,197 Right of use
Slide 19: Historical P&L Statements
Historical P&L Statements Audited Audited Change (%) TLm 2025 2024 Revenues 55,093 51,951 %6.0 Cost of service (-) (39,605) (37,738) %4.9 Gross profit 15,488 14,213 %9.0 General administration expenses (-) (4,750) (4,407) %7.8 Other income from operations 2,056 1,022 %101.2 Other expenses from opera
Slide 20: EBITDA Reconciliation
EBITDA Reconciliation TLm 2025 2024 Change (%) Revenue 55,093 51,951 6.0% Cost of service (39,605) (37,738) 4.9% Gross profit 15,488 14,213 9.0% General administrative expenses (-) (4,750) (4,407) 7,8% Depreciation and amortization expenses (Cost of service) 4,411 3,307 33.4% Depreciation and amorti